State-Level Social Vulnerability Index and Healthcare Access: The Behavioral Risk Factor Surveillance System Survey.


Journal

American journal of preventive medicine
ISSN: 1873-2607
Titre abrégé: Am J Prev Med
Pays: Netherlands
ID NLM: 8704773

Informations de publication

Date de publication:
09 2022
Historique:
received: 01 12 2021
revised: 07 03 2022
accepted: 09 03 2022
pubmed: 4 5 2022
medline: 24 8 2022
entrez: 3 5 2022
Statut: ppublish

Résumé

Access to health care is affected by social determinants of health. The social vulnerability index encompasses multiple social determinants of health simultaneously and may therefore be associated with healthcare access. Cross-sectional data were used from the 2016‒2019 Behavioral Risk Factor Surveillance System, a nationally representative U.S. telephone-based survey of adults aged ≥18 years. State-level social vulnerability index was derived using county-level social vulnerability index estimates from the Centers for Disease Control and Prevention Agency for Toxic Substances and Disease Registry. Analyses were performed in October 2021. Social vulnerability index was ranked according to percentiles, which were divided into tertiles: Tertile 1 (0.10-0.32), Tertile 2 (0.33-0.53), and Tertile 3 (0.54-0.90). In multivariable-adjusted models comparing U.S. states in Tertile 3 with those in Tertile 1 of social vulnerability index, there was a higher prevalence of absence of healthcare coverage (OR=1.39 [95% CI=1.22, 1.58]), absence of primary care provider (OR=1.34 [95% CI=1.22, 1.48]), >1-year duration since last routine checkup (OR=1.18 [95% CI=1.10, 1.27]), inability to see a doctor because of cost (OR=1.38 [95% CI=1.23, 1.54]), and the composite variable of any difficulty in accessing healthcare (OR=1.15 [95% CI=1.08, 1.22]). State-level social vulnerability is associated with several measures related to healthcare access. These results can help to identify targeted interventions to improve access to health care in U.S. states with high social vulnerability index burden.

Identifiants

pubmed: 35504796
pii: S0749-3797(22)00160-X
doi: 10.1016/j.amepre.2022.03.008
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

403-409

Informations de copyright

Published by Elsevier Inc.

Auteurs

Mahmoud Al Rifai (M)

Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas.

Vardhmaan Jain (V)

Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio.

Safi U Khan (SU)

Department of Cardiology, DeBakey Heart & Vascular Center, Houston Methodist, Houston, Texas.

Anupama Bk (A)

Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas.

Jamal H Mahar (JH)

Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas.

Chayakrit Krittanawong (C)

Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas.

Shiva Raj Mishra (SR)

Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.

Sourbha S Dani (SS)

Department of Cardiology, Lahey Hospital & Medical Center, Burlington, Massachusetts.

Laura A Petersen (LA)

Health Policy, Quality & Informatics Program, Michael E.DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality, Effectiveness, and Safety, Houston, Texas; Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas.

Salim S Virani (SS)

Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas; Health Policy, Quality & Informatics Program, Michael E.DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality, Effectiveness, and Safety, Houston, Texas; Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas; Section of Cardiology, Michael E. DeBakey Department of Veterans Affairs Medical Center, Houston, Texas. Electronic address: virani@bcm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH